COMPANY RESEARCH PROFILE · UPDATED 2026-09-29

Sinocelltech

Biotechnology company developing recombinant proteins, monoclonal antibodies and vaccines for cancer, autoimmune and hematologic conditions.

TICKER688520.SS

HEADQUARTERSBeijing, China

STAGEApproved

ACTIVE TRIALS27

Therapeutic areas

OncologyAutoimmuneHematology

Selected products and programs

SCT800SCT510

Linked curated drug profiles

No curated drug entity is linked in the current pilot.

Selected active clinical trials

A Study to Evaluate the Safety and Tolerability of SCTB14 as First-Line Therapy in Non-Small Cell Lung Cancer.

Phase 3 · Recruiting · Non-Small Cell Lung Carcinoma (NSCLC)

A Study to Evaluate the Safety and Efficacy of SCTB35 in Combination With Gemcitabine and Oxaliplatin in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Phase 3 · Recruiting · DLBCL - Diffuse Large B Cell Lymphoma

A Study to Evaluate the Safety and Efficacy of SCTC21C in Combination With Bortezomib, Cyclophosphamide, and Dexamethasone in Patients With Newly Diagnosed Systemic Light-Chain Amyloidosis (NDSLCA)

Phase 3 · Recruiting · Amyloidosis

A Study to Evaluate the Safety and Efficacy of SCTC21C in Combination With Bortezomib, Lenalidomide and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant

Phase 3 · Recruiting · Multiple Myeloma (MM)

A Study to Evaluate the Safety and Efficacy of SCTB35 in Combination With Lenalidomide in Patients With Relapsed or Refractory Follicular Lymphoma

Phase 3 · Recruiting · Follicular Lymphoma (FL)

Efficacy and Safety Evaluation Study of SCT800 in Previously Untreated Hemophilia A Patients.

Phase 3 · Recruiting · Haemophilia A

Selected patent records

No linked FDA Orange Book patent record was found for the selected products.

Primary and company sources

Company and pipeline information can change. Verify material decisions against the linked primary sources.

Evidence & limits

Source: Open the source record

Record identifier: /companies/sinocelltech/
Event / action date: Not separately retained
Source update date: Not separately retained
Platform retrieval / processing date: Not separately retained

What it supports. Connections found through the catalog, identifiers, or name and alias matching, with source links where retained.

Limits. A company association is not proof of ownership or sponsorship of every linked record. Product, substance, parent-company, and subsidiary relationships may differ.

Connection basis. Catalog, identifier, or normalized name association. Product and company connections are research leads, not ownership determinations.

What this record means · Report an issue with this record